Class information for:
Level 2: MULTIPLE MYELOMA//THALIDOMIDE//MYELOMA

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
605 13295 33.2 72%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)



ID, lev.
above
Publications Label for level above
398 27726 MULTIPLE MYELOMA//AMYLOIDOSIS//THALIDOMIDE

Classes in level below (level 1)



ID, lev. below Publications Label for level below
693 3091 MULTIPLE MYELOMA//LENALIDOMIDE//BORTEZOMIB
2367 2198 PLASMA CELL LEUKEMIA//PRIMARY PLASMA CELL LEUKEMIA//MMSET
5882 1493 THALIDOMIDE//CC 5013//CC 4047
6328 1433 PLASMACYTOMA//EXTRAMEDULLARY PLASMACYTOMA//SOLITARY PLASMACYTOMA
6796 1366 IMMUNOFIXATION ELECTROPHORESIS//FREE LIGHT CHAINS//SERUM FREE LIGHT CHAINS
8013 1227 LIGHT CHAIN DEPOSITION DISEASE//CRYSTAL STORING HISTIOCYTOSIS//HEAVY CHAIN DEPOSITION DISEASE
8161 1213 MYELOMA BONE DISEASE//CAM DR//HEIM
12099 868 WALDENSTROMS MACROGLOBULINEMIA//WALDENSTROM MACROGLOBULINEMIA//BING WALDENSTROMS MACROGLOBULINEMIA
23918 276 MOTT CELL//RUSSELL BODIES//MOTT CELLS
30929 130 MU HEAVY CHAIN DISEASE//HEAVY CHAIN DISEASE//GAMMA HEAVY CHAIN DISEASE

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of publ.
in class
1 MULTIPLE MYELOMA Author keyword 2091 48% 24% 3212
2 THALIDOMIDE Author keyword 847 58% 7% 966
3 MYELOMA Author keyword 437 44% 6% 765
4 LENALIDOMIDE Author keyword 311 54% 3% 404
5 PLASMACYTOMA Author keyword 247 56% 2% 297
6 BORTEZOMIB Author keyword 206 34% 4% 503
7 EXTRAMEDULLARY PLASMACYTOMA Author keyword 203 82% 1% 117
8 LIGHT CHAIN DEPOSITION DISEASE Author keyword 185 91% 1% 78
9 PLASMA CELL LEUKEMIA Author keyword 167 84% 1% 92
10 MYELOMA THER Y Address 144 54% 1% 188

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of publ.
in class
LCSH search Wikipedia search
1 MULTIPLE MYELOMA 2091 48% 24% 3212 Search MULTIPLE+MYELOMA Search MULTIPLE+MYELOMA
2 THALIDOMIDE 847 58% 7% 966 Search THALIDOMIDE Search THALIDOMIDE
3 MYELOMA 437 44% 6% 765 Search MYELOMA Search MYELOMA
4 LENALIDOMIDE 311 54% 3% 404 Search LENALIDOMIDE Search LENALIDOMIDE
5 PLASMACYTOMA 247 56% 2% 297 Search PLASMACYTOMA Search PLASMACYTOMA
6 BORTEZOMIB 206 34% 4% 503 Search BORTEZOMIB Search BORTEZOMIB
7 EXTRAMEDULLARY PLASMACYTOMA 203 82% 1% 117 Search EXTRAMEDULLARY+PLASMACYTOMA Search EXTRAMEDULLARY+PLASMACYTOMA
8 LIGHT CHAIN DEPOSITION DISEASE 185 91% 1% 78 Search LIGHT+CHAIN+DEPOSITION+DISEASE Search LIGHT+CHAIN+DEPOSITION+DISEASE
9 PLASMA CELL LEUKEMIA 167 84% 1% 92 Search PLASMA+CELL+LEUKEMIA Search PLASMA+CELL+LEUKEMIA
10 WALDENSTROMS MACROGLOBULINEMIA 133 60% 1% 145 Search WALDENSTROMS+MACROGLOBULINEMIA Search WALDENSTROMS+MACROGLOBULINEMIA

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of publ.
in class
1 NEWLY DIAGNOSED MYELOMA 483 87% 2% 240
2 LENALIDOMIDE PLUS DEXAMETHASONE 460 80% 2% 284
3 MULTIPLE MYELOMA 416 18% 16% 2099
4 MONOCLONAL GAMMOPATHY 357 45% 5% 604
5 THALIDOMIDE PLUS DEXAMETHASONE 297 87% 1% 144
6 THALIDOMIDE 284 34% 5% 691
7 CONSENSUS PANEL RECOMMENDATIONS 256 92% 1% 102
8 PLASMA CELL LEUKEMIA 220 84% 1% 122
9 BORTEZOMIB 217 35% 4% 509
10 UNDETERMINED SIGNIFICANCE 217 32% 4% 567

Journals



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 36 24% 1% 132
2 CLINICAL LYMPHOMA & MYELOMA 32 29% 1% 93
3 CLINICAL LYMPHOMA 5 18% 0% 25
4 BLOOD CANCER JOURNAL 5 14% 0% 32

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
MEDICAL PROGRESS Multiple Myeloma 2011 407 80 91%
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma 2009 323 26 96%
Current treatment landscape for relapsed and/or refractory multiple myeloma 2015 4 82 90%
Drug therapy: Multiple myeloma 2004 729 84 82%
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review 2009 275 80 95%
Multiple myeloma 2009 258 113 94%
Genetics of multiple myeloma: another heterogeneity level? 2015 3 60 92%
IMWG consensus on risk stratification in multiple myeloma 2014 28 64 94%
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management 2010 170 21 100%
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders 2009 237 34 82%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MYELOMA THER Y 144 54% 1.4% 188
2 JEROME LIPPER MULTIPLE MYELOMA 102 54% 1.0% 133
3 MYELOMA UNIT 87 72% 0.5% 68
4 BING WALDENSTROMS MACROGLOBULINEMIA 63 77% 0.3% 43
5 AZIENDA OSPED S GIOVANNI BATTISTA 35 64% 0.3% 35
6 DONNA D DONALD M LAMBERT MYELOMA GENET 33 77% 0.2% 23
7 SERAGNOLI HEMATOL 32 78% 0.2% 21
8 MULTIPLE MYELOMA SECT 30 68% 0.2% 27
9 IST EMATOL SERAGNOLI 27 71% 0.2% 22
10 CLIN THER EUT 26 15% 1.2% 158

Related classes at same level (level 2)



Rank Relatedness score Related classes
1 0.0000012436 AMYLOIDOSIS//TRANSTHYRETIN//AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
2 0.0000007610 CHRONIC LYMPHOCYTIC LEUKEMIA//HAIRY CELL LEUKEMIA//CLL
3 0.0000006762 THROMBOPOIETIN//ONCOSTATIN M//LEUKEMIA INHIBITORY FACTOR
4 0.0000006450 CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//VINFLUNINE//VINCRISTINE
5 0.0000006025 BISPHOSPHONATES//ZOLEDRONIC ACID//BISPHOSPHONATE
6 0.0000005987 PROTEASOME//UBIQUITIN//NEDD8
7 0.0000004791 GUILLAIN BARRE SYNDROME//CASTLEMANS DISEASE//POEMS SYNDROME
8 0.0000004572 MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA
9 0.0000003985 ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS
10 0.0000003893 FIBRILLARY GLOMERULONEPHRITIS//NAIL PATELLA SYNDROME//YELLOW NAIL SYNDROME